MUFG Securities Americas’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.79M Buy
6,107
+120
+2% +$39.4K 0.12% 171
2025
Q4
$2.1M Sell
5,987
-86
-1% -$29.1K 0.13% 136
2025
Q3
$1.96M Buy
6,073
+1,066
+21% +$332K 0.13% 146
2025
Q2
$1.95M Buy
5,007
+901
+22% +$362K 0.17% 117
2025
Q1
$1.79M Buy
4,106
+682
+20% +$274K 0.21% 97
2024
Q4
$1.26M Buy
+3,424
New +$1.43M 0.16% 117

Other funds holding ELV

MUFG Securities Americas's ELV Position: Q1 2026 in Review

MUFG Securities Americas increased its Elevance Health (ELV) stake by 2% in Q1 2026, buying an estimated $39.4K and bringing the position to 6,107 shares worth $1.79M. The position accounts for 0.12% of the portfolio, ranked #171.

MUFG Securities Americas first reported a position in ELV in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.1M in Q4 2025. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • MUFG Securities Americas held 6,107 shares of Elevance Health worth $1.79M as of Q1 2026.
  • MUFG Securities Americas bought 120 Elevance Health shares in Q1 2026, an estimated $39.4K.
  • Elevance Health made up 0.12% of MUFG Securities Americas's portfolio in Q1 2026, its #171 holding.
  • MUFG Securities Americas first reported a position in Elevance Health in Q4 2024 and has held it in 6 quarters since.
  • MUFG Securities Americas's Elevance Health position peaked at $2.1M in Q4 2025.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on MUFG Securities Americas's 13F filing for Q1 2026, filed 11 May 2026.